-
Biogennix appoints new CFO: 5 things to know
Orthobiologics company Biogennix named Robert Bazier its new CFO. -
CollPlant names new board chairman: 4 insights
Regenerative medicine company CollPlant appointed Jonathan M.N. Rigby as chairman of the board of directors. -
Ortho RTi releases results of 2 regenerative medicine studies
Ortho Regenerative Technologies published the results of two scientific studies validating its product's ability to improve the repair of rotator cuff tendon and articular cartilage tissue. -
California neuroscience institute joins regenerative medicine clinical trial: 5 notes
The Pacific Brain Tumor Center at Santa Monica, Calif.-based Pacific Neuroscience Institute will serve as the leading enrollment site for Medicenna Therapeutics' clinical trial. -
ThermoGenesis makes orthopedic partnership: 3 notes
ThermoGenesis Corp. entered into a supply agreement with Los Angeles-based Orthohealing Center Management. -
CDC investigates contaminated stem cell products: 5 things to know
The CDC is investigating bacterial infections in patients who received stem cell treatments from the ReGen Series, distributed by Liveyon. -
Global spine biologics market to hit $2.7B by 2024 — 18 key players
The global spine biologics market is expected to reach $2.7 billion by 2024, increasing at a 4.4 percent compound annual growth rate, according to a Data Bridge Market Research report. -
U of Missouri to release biojoint records amid allegations of false marketing: 5 things to know
Judge Brouck Jacobs ordered the Columbia-based University of Missouri to comply with a discovery request of its biojoint surgery records, according to the Columbia Tribune. -
Japan approves stem cell treatment for SCI — Some researchers doubt efficacy
Japan approved Stemirac, a stem cell treatment for spinal cord injuries, Nature reports. -
Clinical trial proves stem cells effective to treat spinal cord injuries: 5 notes
Asterias Biotherapeutics conducted a clinical trial to study the effectiveness of its OPC1 cells, Seeking Alpha reports. The company released its one-year results. -
AAHKS recommends against biologic therapies for advanced hip, knee arthritis: 3 things to know
The American Association of Hip and Knee Surgeons does not currently recommend biologic treatments for advanced hip or knee arthritis, according to a new position statement. -
Dr. Christopher Centeno urges lawmakers to curb unregulated stem cell treatments: 5 insights
Broomfield, Colo.-based Centeno-Schultz Clinic's Christopher J. Centeno, MD, is urging Colorado legislators to crackdown on unregulated stem cell treatments, The Denver Channel reports. -
California orthopedic practice now offers Lipogems
Rancho Mirage, Calif.-based Star Ortho is now offering Lipogems as an alternative or supplement to orthopedic surgery. -
Biomaterials market to exceed $173B by 2022 — 10 top market competitors
The global biomaterials market is predicted to reach more than $173 billion by 2022, growing at a 16 percent compound annual growth rate, according to a Market Research Engine report. -
Are stem cells the future for spine surgery? Dr. Sameer Mathur explains
More and more surgeons are beginning to talk about biologics, stem cells and regenerative medicine. Sameer Mathur, MD, an orthopedic surgeon, explains the future of stem cells in a sponsored article with WRAL.com. -
Dr. Bert Mandelbaum describes potential of orthobiologic treatments for ACL tears in 'Medscape'
Bert Mandelbaum, MD, described the evidence supporting orthobiologic treatments for torn anterior cruciate ligaments in a Medscape column. -
Anika Therapeutics to showcase cartilage repair scaffold solution: 4 things to know
Anika Therapeutics will showcase its Hyalofast cartilage repair scaffold at the 2019 International Cartilage Repair Society Summit in San Diego, Jan. 17-18. -
Georgia orthopedic surgeon uses patients' body fat to repair damaged tissue: 5 notes
Hughston Clinic of Columbus (Ga.) orthopedic surgeon Champ Baker Jr., MD, implemented Lipogems technology to help repair patients' damaged tissue. -
SPR Therapeutics names pain management specialist as chief medical advisor: 3 notes
SPR Therapeutics appointed Peter Staats, MD, to chief medical advisor. -
'A new class of bio-integrative implants': Dr. Stuart Miller on orthobiologics and implant selection
Stuart Miller, MD, is an orthopedic surgeon at MedStar Union Memorial Hospital and assistant professor at Johns Hopkins University School of Medicine, both based in Baltimore.
Page 22 of 34